---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-002575"
form_type: "8-K"
ticker: "SIGY"
cik: "0001642159"
company_name: "Sigyn Therapeutics, Inc."
filed_at: "2025-01-16T23:59:59+00:00"
generated_at: "2026-05-28T00:05:19.613161+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Sigyn Therapeutics appoints Michael Ryan to board effective Jan 11, 2025

## Summary
- Michael Ryan appointed to board; will serve until next stockholder meeting or successor elected.
- Ryan is a founder director of Irrus Investments, largest angel syndicate in Ireland, with €40M+ invested in 35 life science and tech firms.
- Compensation: $30,000 annual cash retainer plus $50,000 in restricted stock units or options, vesting quarterly over one year.
- Previously CEO of Sedana Medical (Nasdaq First North) and Artema Medical (acquired by Datascope).

## SEC filing metadata
- accession: 0001493152-25-002575
- form_type: 8-K
- ticker: SIGY
- cik: 0001642159
- company_name: Sigyn Therapeutics, Inc.
- filed_at: 2025-01-16T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1642159/000149315225002575/0001493152-25-002575-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1642159/000149315225002575/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-002575
- JSON: https://secwatch.observer/filing/0001493152-25-002575.json
- Plain text: https://secwatch.observer/filing/0001493152-25-002575.txt

## Key facts
- Executive change
  Michael Ryan was appointed as Director at Sigyn Therapeutics, Inc..
  - Action: appointed
  - Role: Director
  source text: On January 11, 2025, our Board of Directors appointed Michael Ryan to our Board of Directors.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1642159/000149315225002575/0001493152-25-002575-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.